Bio-Rad Laboratories | BIO - Debt


Bio-Rad Laboratories reported $1.37B in Debt for its fiscal quarter ending in June of 2026.





Debt Change Date
Abbott USD 34.05B 20.19B Mar/2026
Agilent USD 3.36B 1000K Mar/2026
Becton, Dickinson and Co. USD 16.81B 471M Jun/2026
Bio Techne USD 200M 0 Jun/2026
Bio-Rad Laboratories USD 1.37B 7.8M Jun/2026
Bruker USD 1.82B 153.5M Jun/2026
Charles River Laboratories USD 3.03B 28.55M Jun/2026
Danaher USD 26.48B 76M Sep/2026
General Electric Aerospace USD 19.33B 169M Sep/2026
Illumina USD 2.54B 9M Mar/2026
IQVIA Holdings USD 16.07B 174M Sep/2026
Laboratory Of America USD 6.77B 474.5M Jun/2026
Merck USD 53.91B 4.79B Jun/2026
Mettler Toledo International USD 2.11B 116.68M Jun/2026
Myriad Genetics USD 59.3M 19.7M Mar/2025
OraSure Technologies USD 782K 465K Jun/2024
Pacific Biosciences Of California USD 892.24M 653K Dec/2023
Quest Diagnostics USD 6.38B 23M Jun/2026
Repligen USD 555.6M 135.35M Sep/2026
Revvity USD 2.63B 707.45M Sep/2026
Roche Holding CHF 33.03B 1.41B Jun/2025
Siemens EUR 47.22B 2.7B Sep/2026
Standard Biotools USD 28.09M 1.4M Jun/2026
Thermo Fisher Scientific USD 42.55B 612M Jun/2026
Tosoh JPY 261.55B 32.64B Sep/2026
Waters USD 5.45B 116M Jun/2026